STOCK TITAN

[Form 4] Vicarious Surgical Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Sammy Khalifa, Chief Technology Officer, Director, and 10% Owner of Vicarious Surgical (RBOT), reported a tax-related transaction on June 23, 2025. The insider sold 223 shares of Class A Common Stock at a weighted average price of $7.8145 per share (ranging from $7.62 to $7.885).

Key details of the transaction:

  • The sale was specifically executed to cover tax withholding obligations related to the vesting of restricted stock units originally granted on November 23, 2021
  • Following the transaction, Khalifa maintains direct ownership of 35,407 shares
  • The transaction was reported through Form 4 filed on June 24, 2025

This insider transaction appears to be a routine tax-related sale rather than a discretionary trading decision, as it was triggered by RSU vesting obligations.

Sammy Khalifa, Chief Technology Officer, Direttore e proprietario del 10% di Vicarious Surgical (RBOT), ha riportato una transazione fiscale il 23 giugno 2025. L'insider ha venduto 223 azioni di Azioni Ordinarie Classe A a un prezzo medio ponderato di 7,8145 $ per azione (con un range da 7,62 $ a 7,885 $).

Dettagli principali della transazione:

  • La vendita è stata effettuata specificamente per coprire le obbligazioni fiscali relative al vesting delle unità azionarie vincolate (RSU) originariamente concesse il 23 novembre 2021
  • Dopo la transazione, Khalifa mantiene la proprietà diretta di 35.407 azioni
  • La transazione è stata segnalata tramite il Modulo 4 depositato il 24 giugno 2025

Questa transazione interna sembra essere una vendita ordinaria legata a motivi fiscali piuttosto che una decisione di trading discrezionale, essendo stata causata dalle obbligazioni di vesting delle RSU.

Sammy Khalifa, Director de Tecnología, Director y propietario del 10% de Vicarious Surgical (RBOT), reportó una transacción relacionada con impuestos el 23 de junio de 2025. El insider vendió 223 acciones de acciones ordinarias Clase A a un precio promedio ponderado de $7.8145 por acción (con un rango de $7.62 a $7.885).

Detalles clave de la transacción:

  • La venta se realizó específicamente para cubrir obligaciones fiscales relacionadas con la adquisición de unidades restringidas de acciones originalmente otorgadas el 23 de noviembre de 2021
  • Tras la transacción, Khalifa mantiene la propiedad directa de 35,407 acciones
  • La transacción fue reportada mediante el Formulario 4 presentado el 24 de junio de 2025

Esta transacción interna parece ser una venta rutinaria relacionada con impuestos en lugar de una decisión discrecional de trading, ya que fue motivada por obligaciones de adquisición de las RSU.

샘미 칼리파, 최고기술책임자(CTO), 이사 및 Vicarious Surgical(RBOT)의 10% 지분 보유자가 2025년 6월 23일 세금 관련 거래를 보고했습니다. 내부자는 223주의 클래스 A 보통주를 주당 7.8145달러의 가중평균 가격(7.62달러에서 7.885달러 사이)으로 매도했습니다.

거래 주요 내용:

  • 이번 매도는 2021년 11월 23일에 부여된 제한 주식 단위(RSU)의 베스팅에 따른 세금 원천징수 의무를 충당하기 위해 이루어졌습니다
  • 거래 후 칼리파는 35,407주를 직접 보유하고 있습니다
  • 이 거래는 2025년 6월 24일 제출된 Form 4를 통해 보고되었습니다

이번 내부자 거래는 RSU 베스팅에 따른 세금 의무로 인해 발생한 것으로, 임의적인 거래 결정이 아닌 일상적인 세금 관련 매도인 것으로 보입니다.

Sammy Khalifa, Directeur Technique, Administrateur et détenteur de 10 % de Vicarious Surgical (RBOT), a déclaré une transaction liée aux impôts le 23 juin 2025. L'initié a vendu 223 actions de classe A à un prix moyen pondéré de 7,8145 $ par action (variant de 7,62 $ à 7,885 $).

Détails clés de la transaction :

  • La vente a été réalisée spécifiquement pour couvrir les obligations fiscales liées à l'acquisition des unités d'actions restreintes initialement attribuées le 23 novembre 2021
  • Après la transaction, Khalifa conserve la propriété directe de 35 407 actions
  • La transaction a été signalée via le formulaire 4 déposé le 24 juin 2025

Cette transaction d'initié semble être une vente courante liée à des obligations fiscales plutôt qu'une décision de trading discrétionnaire, déclenchée par les obligations d'acquisition des RSU.

Sammy Khalifa, Chief Technology Officer, Direktor und 10% Eigentümer von Vicarious Surgical (RBOT), meldete am 23. Juni 2025 eine steuerbezogene Transaktion. Der Insider verkaufte 223 Aktien der Klasse A Stammaktien zu einem gewichteten Durchschnittspreis von 7,8145 $ pro Aktie (Spanne von 7,62 $ bis 7,885 $).

Wichtige Details der Transaktion:

  • Der Verkauf erfolgte speziell, um Steuerabzugsverpflichtungen im Zusammenhang mit der Vesting von ursprünglich am 23. November 2021 gewährten Restricted Stock Units (RSUs) zu erfüllen
  • Nach der Transaktion hält Khalifa weiterhin direkt 35.407 Aktien
  • Die Transaktion wurde über das am 24. Juni 2025 eingereichte Formular 4 gemeldet

Diese Insider-Transaktion scheint eine routinemäßige steuerbedingte Veräußerung zu sein und keine diskretionäre Handelsentscheidung, da sie durch RSU-Vesting-Verpflichtungen ausgelöst wurde.

Positive
  • None.
Negative
  • None.

Sammy Khalifa, Chief Technology Officer, Direttore e proprietario del 10% di Vicarious Surgical (RBOT), ha riportato una transazione fiscale il 23 giugno 2025. L'insider ha venduto 223 azioni di Azioni Ordinarie Classe A a un prezzo medio ponderato di 7,8145 $ per azione (con un range da 7,62 $ a 7,885 $).

Dettagli principali della transazione:

  • La vendita è stata effettuata specificamente per coprire le obbligazioni fiscali relative al vesting delle unità azionarie vincolate (RSU) originariamente concesse il 23 novembre 2021
  • Dopo la transazione, Khalifa mantiene la proprietà diretta di 35.407 azioni
  • La transazione è stata segnalata tramite il Modulo 4 depositato il 24 giugno 2025

Questa transazione interna sembra essere una vendita ordinaria legata a motivi fiscali piuttosto che una decisione di trading discrezionale, essendo stata causata dalle obbligazioni di vesting delle RSU.

Sammy Khalifa, Director de Tecnología, Director y propietario del 10% de Vicarious Surgical (RBOT), reportó una transacción relacionada con impuestos el 23 de junio de 2025. El insider vendió 223 acciones de acciones ordinarias Clase A a un precio promedio ponderado de $7.8145 por acción (con un rango de $7.62 a $7.885).

Detalles clave de la transacción:

  • La venta se realizó específicamente para cubrir obligaciones fiscales relacionadas con la adquisición de unidades restringidas de acciones originalmente otorgadas el 23 de noviembre de 2021
  • Tras la transacción, Khalifa mantiene la propiedad directa de 35,407 acciones
  • La transacción fue reportada mediante el Formulario 4 presentado el 24 de junio de 2025

Esta transacción interna parece ser una venta rutinaria relacionada con impuestos en lugar de una decisión discrecional de trading, ya que fue motivada por obligaciones de adquisición de las RSU.

샘미 칼리파, 최고기술책임자(CTO), 이사 및 Vicarious Surgical(RBOT)의 10% 지분 보유자가 2025년 6월 23일 세금 관련 거래를 보고했습니다. 내부자는 223주의 클래스 A 보통주를 주당 7.8145달러의 가중평균 가격(7.62달러에서 7.885달러 사이)으로 매도했습니다.

거래 주요 내용:

  • 이번 매도는 2021년 11월 23일에 부여된 제한 주식 단위(RSU)의 베스팅에 따른 세금 원천징수 의무를 충당하기 위해 이루어졌습니다
  • 거래 후 칼리파는 35,407주를 직접 보유하고 있습니다
  • 이 거래는 2025년 6월 24일 제출된 Form 4를 통해 보고되었습니다

이번 내부자 거래는 RSU 베스팅에 따른 세금 의무로 인해 발생한 것으로, 임의적인 거래 결정이 아닌 일상적인 세금 관련 매도인 것으로 보입니다.

Sammy Khalifa, Directeur Technique, Administrateur et détenteur de 10 % de Vicarious Surgical (RBOT), a déclaré une transaction liée aux impôts le 23 juin 2025. L'initié a vendu 223 actions de classe A à un prix moyen pondéré de 7,8145 $ par action (variant de 7,62 $ à 7,885 $).

Détails clés de la transaction :

  • La vente a été réalisée spécifiquement pour couvrir les obligations fiscales liées à l'acquisition des unités d'actions restreintes initialement attribuées le 23 novembre 2021
  • Après la transaction, Khalifa conserve la propriété directe de 35 407 actions
  • La transaction a été signalée via le formulaire 4 déposé le 24 juin 2025

Cette transaction d'initié semble être une vente courante liée à des obligations fiscales plutôt qu'une décision de trading discrétionnaire, déclenchée par les obligations d'acquisition des RSU.

Sammy Khalifa, Chief Technology Officer, Direktor und 10% Eigentümer von Vicarious Surgical (RBOT), meldete am 23. Juni 2025 eine steuerbezogene Transaktion. Der Insider verkaufte 223 Aktien der Klasse A Stammaktien zu einem gewichteten Durchschnittspreis von 7,8145 $ pro Aktie (Spanne von 7,62 $ bis 7,885 $).

Wichtige Details der Transaktion:

  • Der Verkauf erfolgte speziell, um Steuerabzugsverpflichtungen im Zusammenhang mit der Vesting von ursprünglich am 23. November 2021 gewährten Restricted Stock Units (RSUs) zu erfüllen
  • Nach der Transaktion hält Khalifa weiterhin direkt 35.407 Aktien
  • Die Transaktion wurde über das am 24. Juni 2025 eingereichte Formular 4 gemeldet

Diese Insider-Transaktion scheint eine routinemäßige steuerbedingte Veräußerung zu sein und keine diskretionäre Handelsentscheidung, da sie durch RSU-Vesting-Verpflichtungen ausgelöst wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Khalifa Sammy

(Last) (First) (Middle)
C/O VICARIOUS SURGICAL INC.
78 FOURTH AVENUE

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/23/2025 S(1) 223 D $7.8145(2) 35,407 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.
2. This figure is the weighted average sales price of multiple trades ranging from $7.62 to $7.885 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
/s/ Erin Checka, Attorney-in-Fact 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many RBOT shares did CTO Sammy Khalifa sell on June 23, 2025?

According to the Form 4 filing, CTO Sammy Khalifa sold 223 shares of Vicarious Surgical Inc. (RBOT) Class A Common Stock on June 23, 2025.

What was the price of RBOT shares sold by Khalifa in the June 2025 transaction?

The shares were sold at a weighted average price of $7.8145 per share, with individual trades ranging from $7.62 to $7.885 per share.

Why did RBOT's CTO Sammy Khalifa sell shares in June 2025?

The sales were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were originally granted on November 23, 2021.

How many RBOT shares does Sammy Khalifa own after the June 2025 transaction?

Following the reported transaction, Sammy Khalifa directly owns 35,407 shares of Vicarious Surgical Inc. (RBOT) Class A Common Stock.

What positions does Sammy Khalifa hold at RBOT as of June 2025?

Sammy Khalifa holds multiple positions at Vicarious Surgical Inc. (RBOT): Chief Technology Officer, Director, and is also a 10% Owner of the company.
Vicarious Surgical Inc

NYSE:RBOT

RBOT Rankings

RBOT Latest News

RBOT Latest SEC Filings

RBOT Stock Data

46.57M
4.06M
26.35%
34.1%
1.88%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WALTHAM